echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > No need to be stabbed, the FDA urgently authorized the first new crown breathing test platform, blow your breath, and get the results in three minutes

    No need to be stabbed, the FDA urgently authorized the first new crown breathing test platform, blow your breath, and get the results in three minutes

    • Last Update: 2022-05-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The U.
    S.
    Food and Drug Administration (FDA) has
    urgently authorized the first diagnostic test for COVID-19 based on a breath sample
    .
    No nasal swabs or throat swabs are needed, only the exhaled gas needs to be tested, and the test results can be obtained in less than three minutes

    .

    The U.
    S.
    Food and Drug Administration (FDA) has urgently authorized the first diagnostic test for COVID-19 based on a breath sample

    .
    No nasal swabs or throat swabs are required, only the exhaled gas needs to be tested, and the test results can be obtained in less than three minutes

    This is the first Emergency Use Authorization (EUA) issued by the FDA to diagnose COVID-19 by detecting compounds associated with COVID-19 infection in breath samples
    .
    The size of this device is close to an ordinary suitcase.
    Due to the portability of the device, it can be used in multiple scenarios such as hospitals, doctors' offices, public places, and mobile monitoring stations

    .

    People only need to blow air through a disposable straw under the guidance of a trained operator, and the device can complete the collection and detection of breath samples, and the test results can be obtained in less than 3 minutes
    .

    Developed by InspectIR, the Covid-19 breath analyzer uses gas chromatography-mass spectrometry (GC-MS) to separate and identify compounds in exhaled breath and quickly detect 5 volatile species associated with Covid-19 infection.
    organic compounds

    .
    Once the presence of the five markers was detected, the analyzer showed a positive test result, a process that took less than three minutes

    .

    The effectiveness of the new crown breath analyzer was previously confirmed in a large study of 2,409 people (including symptomatic, asymptomatic, and uninfected people), and the results showed that the analyzer had a detection sensitivity of 91.
    2% ( This means, out of 1,000 positive patients, 912 can be detected)

    .
    The detection specificity was 99.
    6% (meaning, out of 1000 negative populations, only 4 false positives occurred)

    .
    In addition, subsequent tests for Omicron showed similar sensitivity and specificity

    .

    The FDA also reminded that samples tested positive by the new crown breath analyzer should be further confirmed by nucleic acid testing
    .
    For negative samples, it can be judged based on the recent contact history of the tested person, the history of disease, and the presence of symptoms related to the new crown

    .
    This test result should not be used as the sole basis for treatment, patient management, or disease control

    .

    Dr.
    Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, said that this authorization is another example of rapid innovation in new crown diagnostic tests.
    Prepare for possible public health emergencies

    .

    InspectIR previously focused on developing portable breath analyzers for opioid and cannabis detection
    .
    In the wake of the Covid-19 pandemic, InspectIR began research and development of a portable breath analyzer to detect Covid-19

    .



    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.